BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Ying Chen, Changshun Yu, Xueru Yin, Xiaolei Guo, Shangwei Wu, Jinlin Hou. Hepatitis C virus genotypes and subtypes circulating in Mainland ChinaEmerging Microbes & Infections 2017; 6(1): 1 doi: 10.1038/emi.2017.77
2
Onyema Ogbuagu, Gerald Friedland, R. Douglas Bruce. Drug interactions between buprenorphine, methadone and hepatitis C therapeuticsExpert Opinion on Drug Metabolism & Toxicology 2016; 12(7): 721 doi: 10.1080/17425255.2016.1183644
3
Joseph Bick, Gabriel Culbert, Haider A. Al-Darraji, Clayton Koh, Veena Pillai, Adeeba Kamarulzaman, Frederick Altice. Healthcare resources are inadequate to address the burden of illness among HIV-infected male prisoners in MalaysiaInternational Journal of Prisoner Health 2016; 12(4): 253 doi: 10.1108/IJPH-06-2016-0017
4
Carlos Roncero, Richard Littlewood, Pablo Vega, Jose Martinez-Raga, Marta Torrens. Chronic hepatitis C and individuals with a history of injecting drugs in SpainEuropean Journal of Gastroenterology & Hepatology 2017; 29(6): 629 doi: 10.1097/MEG.0000000000000855
5
Jing Lu, Li Zhang, Xiaoqin Xu, Yuanfang Chen, Ying Zhou, Zhi Zhang, Gengfeng Fu, Guohong Chen. Hepatitis C virus genotype diversity and distribution among methadone maintenance treatment patients in Jiangsu, ChinaDrug and Alcohol Dependence 2019; 194: 101 doi: 10.1016/j.drugalcdep.2018.09.026
6
Hafsa Aziz, Shazia Fatima, Mohammad Faheem. Indeterminate Prediction of Hepatitis C Virus Genotype by Commercial Real-Time Polymerase Chain Reaction Assay Resolving by Sequencing to Avoid the Consequence of Inaccurate TypingViral Immunology 2020;  doi: 10.1089/vim.2019.0162
7
Marcello Persico, Andrea Aglitti, Michele Milella, Carmine Coppola, Vincenzo Messina, Ernesto Claar, Ivan Gentile, Fernando Sogari, Paola Pierri, Lorenzo A. Surace, Filomena Morisco, Paolo Tundo, Giuseppina Brancaccio, Gaetano Serviddio, Pietro Gatti, Antonio P. Termite, Giovan G. Di Costanzo, Benedetto Caroleo, Raffaele Cozzolongo, Nicola Coppola, Annamaria Longo, Luca Fontanella, Alessandro Federico, Valerio Rosato, Irene Terrenato, Mario Masarone. Real‐life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL studyLiver International 2019; 39(10): 1852 doi: 10.1111/liv.14170
8
Yadollah Mehrabi, Koorosh Etemad, Alireza Noroozi, Peter Higgs, Maryam Nasirian, Asaad Sharhani, Nahid Khademi, Ahmad Hajebi, Mehdi Noroozi, Ebrahim Shakiba, Behrooz Hamzeh, Mehdi Azizmohammad Looha. Correlates of injecting paraphernalia sharing among male drug injectors in Kermanshah, Iran: implications for HCV preventionJournal of Substance Use 2020; 25(3): 330 doi: 10.1080/14659891.2019.1698670
9
Asaad Sharhani, Yadollah Mehrabi, Alireza Noroozi, Maryam Nasirian, Peter Higgs, Ahmad Hajebi, Behrooz Hamzeh, Nahid Khademi, Mehdi Noroozi, Ebrahim Shakiba, Koorosh Etemad. Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, IranHepatitis Monthly 2017; 17(10) doi: 10.5812/hepatmon.58739
10
Nicola Coppola, Carmine Minichini, Mario Starace, Caterina Sagnelli, Evangelista Sagnelli. Clinical impact of the hepatitis C virus mutations in the era of directly acting antiviralsJournal of Medical Virology 2016; 88(10): 1659 doi: 10.1002/jmv.24527
11
Sevin Kirdar, Neriman Aydin, Yasin Tiryaki, Bulent Ertugrul, Adil Coskun, Mehmet Bilgen. Dynamics of HCV epidemiology in Aydin province of Turkey and the associated factorsAPMIS 2018; 126(2): 109 doi: 10.1111/apm.12790
12
Rachel M. Murdock, Marisa B. Brizzi, Omar Perez, Melissa E. Badowski. Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A ReviewInfectious Diseases and Therapy 2019; 8(1): 23 doi: 10.1007/s40121-018-0228-8
13
Michael Fichter, Keti Piradashvili, Anette Pietrzak-Nguyen, Leah Pretsch, Gabor Kuhn, Susanne Strand, Markus Knuf, Fred Zepp, Frederik R. Wurm, Volker Mailänder, Katharina Landfester, Stephan Gehring. Polymeric hepatitis C virus non-structural protein 5A nanocapsules induce intrahepatic antigen-specific immune responsesBiomaterials 2016; 108: 1 doi: 10.1016/j.biomaterials.2016.08.046
14
Evangelista Sagnelli, Mario Starace, Carmine Minichini, Mariantonietta Pisaturo, Margherita Macera, Caterina Sagnelli, Nicola Coppola. Resistance detection and re-treatment options in hepatitis C virus-related chronic liver diseases after DAA-treatment failureInfection 2018; 46(6): 761 doi: 10.1007/s15010-018-1188-3
15
Angélique Ndjoyi-Mbiguino, Arnaud John Kombe Kombe, Berthold Bivigou-Mboumba, Samira Zoa-Assoumou, Falone Larissa Akombi, Francis Nzengui Nzengui, Hervé M’boyis Kamdem, Sandrine François-Souquière, Jason Blackard. Low prevalence of HCV infection with predominance of genotype 4 among HIV patients living in Libreville, GabonPLOS ONE 2018; 13(1): e0190529 doi: 10.1371/journal.pone.0190529
16
Mohamed A Daw, Abdallah A El-Bouzedi, Mohamed O Ahmed, Aghnyia A Dau, Mohamed M Agnan, Aisha M Drah. Geographic integration of hepatitis C virus: A global threatWorld Journal of Virology 2016; 5(4): 170-182 doi: 10.5501/wjv.v5.i4.170
17
Tahereh Donyavi, Farah Bokharaei-Salim, Khadijeh Khanaliha, Maryam Sheikh, Mohammad-Navid Bastani, Najmeh Moradi, Roghayeh Babaei, Zahra Habib, Atousa Fakhim, Maryam Esghaei. High prevalence of occult hepatitis C virus infection in injection drug users with HIV infectionArchives of Virology 2019; 164(10): 2493 doi: 10.1007/s00705-019-04353-3
18
Mohamed A. Daw, Abdallah El-Bouzedi, Mohamed O. Ahmed, Aghnyia A. Dau, Mohamed M. Agnan. Epidemiology of hepatitis C virus and genotype distribution in immigrants crossing to Europe from North and sub-Saharan AfricaTravel Medicine and Infectious Disease 2016; 14(5): 517 doi: 10.1016/j.tmaid.2016.05.020
19
Ruth M. Lunn, Gloria D. Jahnke, Charles S. Rabkin. Tumour virus epidemiologyPhilosophical Transactions of the Royal Society B: Biological Sciences 2017; 372(1732): 20160266 doi: 10.1098/rstb.2016.0266
20
BENJAMIN CHIN-YEE, S.V. SUBRAMANIAN, AMOL A. VERMA, ANDREAS LAUPACIS, FAHAD RAZAK. Emerging Trends in Clinical Research With Implications for Population Health and Health PolicyThe Milbank Quarterly 2018; 96(2): 369 doi: 10.1111/1468-0009.12328
21
Kamyar Arasteh, Don C. Des Jarlais, Jonathan Feelemyer, Courtney McKnight. Hepatitis C incidence and prevalence among Puerto Rican people who use drugs in New York CityGlobal Public Health 2020; : 1 doi: 10.1080/17441692.2020.1768276
22
Ahmed Abdel Aziz. Hepatitis C in Developing Countries2018; : 3 doi: 10.1016/B978-0-12-803233-6.00001-1
23
Wim Schuermans, Hans Orlent, Isabelle Desombere, Patrick Descheemaeker, Hans Van Vlierberghe, Anja Geerts, Xavier Verhelst, Marijke Reynders, Elizaveta Padalko. Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant FormInternational Journal of Molecular Sciences 2016; 17(9): 1384 doi: 10.3390/ijms17091384